Doktor axborotnomasi 2025, №3 (120)
Subject of the article
MAHALLIY RIVOJLANGAN OSHQOZON SARATONINI TASHXISLASH VA DAVOLASHNING ZAMONAVIY USULLARI (54-57)
Authors
D. Yu. Mamarizayev1, M. D. Juraev2
Institution
1Samarqand davlat tibbiyot universiteti, Samarqand, 2Respublika ixtisoslashtirilgan onkologiya va radiologiya amaliy tibbiyot ilmiy markazi, Toshkent, O'zbekiston
Abstract
Ushbu maqolada mahalliy rivojlangan oshqozon saratoni bo‘yicha olib borilgan tadqiqot natijalari taqdim etil gan. Tadqiqot davomida 2017-2021 yillar oralig‘ida RIOvaRIAATM Samarqand filiali abdominal onkojarrohlik bo‘limida III darajali (T3-4/N+) oshqozon saratoni bilan kasallangan 102 bemor o‘rganildi. Bemorlar 2 guruhga bo‘lingan: birinchi guruh kemoterapisiz operatsiyadan oldin kombinatsiyalangan operatsiya va yordamchi kimyotera piya olgan, ikkinchi guruh esa neoadjuvant kimyoterapiya, jarrohlik va yordamchi kimyoterapiya o‘tgan. Natijalar shuni ko‘rsatdiki, jarrohlik aralashuvlardan so‘ng bemorlarning qo‘shni organlarni rezektsiya qilish bilan birga amalga oshirilgan gastrektomiya natijalari qoniqarli bo‘lgani va operatsiyalardan keyin og‘ir asoratlar juda kam kuzatilgani ma’lum bo‘ldi. Ma’lumki, 48 bemorda neoadjuvant kimyoterapiya o‘tkazilganida, jarayonning barqarorlanishi va re gressiya darajasi 30% dan yuqori bo‘lgan bemorlarda sezilarli yaxshilanishlar ko‘zga tashlandi.
Key words
oshqozon saratoni, mahalliy rivojlangan, neoadyuvant kimyoterapiya, kombinatsion operatsiya, DVARX, FLOT sxemasi.
Literature
1. GLOBOCAN 2020 https://gco.iarc.fr/today/ Дата доступа 22.04.2021. 2. Злокачественные новообразования в России в 2020 году (заболеваемость и смертность ) / под ред. A.A. Ка прина. В. В. Старинского. А. О. Шахзадовой – Москва 2021 . 3. B L Li. Miao. Z Y Li. Progress in gastric cancer with positive peritoneal cytology .Zghua Wei Chang Wai Ke Za Zhi. 2021 May 25 ;24 (9); 458-462. 4. Путова М. В. Носкова К. К. Семенов Н. Е. Хомерики С. Г. Определение свободных опухолевых клеток в перитонеальных смывах при раке желудка – стандартизация этапов пробоподготовки. Лабораторная служ ба 2021 : 10 (1) : 17 -23 . 5. Состояние онкологической помощи населению республики Узбекистан в 2011. 6. Хомяков В.М., Рябов А.Б., Болотина Л.В., Соболев Д.Д., Уткина А.Б., Кузнецова О.С. Лечение больных раком желудка с канцероматозом брюшины. Современный взгляд и перспективы. Онкология. Журнал им. П.А. Гер -цена. 2017 ; 6 (6) : 4–13. 7. Yasufuku I, Nunobe S, Ida S, Kumagai K, Ohashi M, Hiki N, Sano T. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnos tic staging laparoscopy. Gastric Cancer 2020 ; 23 : 319–327. 8. Nakamura M, Ojima T, Nakamori M, et al Conversion surgery for gastric cancer with peritoneal metastasis based on the diagnosis of second-look staging laparoscopy [J]. J Gastrointest Surg, 2019, 23 (9) : 1758–1766. 9. Jamel S, Markar SR, Malietzis G, Acharya A, Athanasiou T, Hanna GB. Prognostic significance of peritoneal lav age cytology in staging gastric cancer : systematic review and meta-analysis. Gastric Cancer 2018 ; 21 : 10–18. 10. Shim HJ, Kim HJ, Lee SH, Bae WK, Hwang EC, Cho SH, Chung IJ, Bang HJ, Hwang JE. Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients, who Under went Radical D2 Gastrectomy. Sci Rep 2020 ; 10 : 9549. 11. Komatsu S, Shioaki Y, Furuke H, Ohta A, Tsuji R, Tanaka S, Kumano T, Imura KI, Shimomura K, Ikeda J, Taniguchi F, Ueshima Y, Lee CJ, Deguchi E, Ikeda E, Otsuji E. Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor? Langenbecks Arch Surg 2019 ; 404 : 599–604. 12. de Bree E, Michelakis D, Stamatiou D, Romanos J, Zoras O. Pharmacological principles of intraperitoneal and bidirectional chemotherapy. Pleura Peritoneum 2017 ; 2 : 47–62.